Mexico Veterinary Ocular Medicine Market Size by Indication (2024–2032)

Demand for effective ocular therapies in animals positioned conjunctivitis as the leading segment in the mexico veterinary ocular medicine market in 2024, was recorded USD 24,103.33 thousand, well ahead of corneal complications at USD 19,647.38 thousand and uveitis at USD 11,877.23 thousand. In 2024, the mexico veterinary ocular medicine market was dominated by conjunctivitis treatments, reflecting the high prevalence of infectious and inflammatory eye conditions in animals. Corneal complications also showed significant market presence, while cataract and eyelid abnormalities remained the smallest segments, indicating comparatively lower therapeutic demand.

By 2025, conjunctivitis is estimated at USD 25,305.19 thousand, continuing to lead the market, while uveitis is expected to reach at USD 12,341.90 thousand. From 2026 to 2032, conjunctivitis maintains dominance, projected to reach USD 39,078.14 thousand by 2032, while glaucoma and retinal complications show steady growth. The sustained mexico veterinary ocular medicine market leadership of conjunctivitis is driven by rising veterinarian focus on preventive care, availability of targeted therapies, and increased awareness of common ocular disorders in animals, positioning it as the most lucrative segment throughout the forecast period.